Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
75 Cards in this Set
- Front
- Back
Class of Fluoxetine
|
SSRI
|
|
Class of sertraline
|
SSRI
|
|
Class of Paroxetine
|
SSRI
|
|
Class of Citalopram
|
SSRI
|
|
Class of Escitalopram
|
SSRI
|
|
MOA of SSRIs
|
Blockade of presynaptic serotonin reuptake to increase synaptic free serotonin concentration and postynaptic serotonin receptor occupancy
|
|
Indications for SSRIs
|
First-line therapy for depression, anxiety
|
|
Class of Venlafaxine
|
SNRIs
|
|
Class of duloxetine
|
SNRIs
|
|
MOA of SNRIs
|
inhibit reuptake of both serotonin and norepinephrine in a similar fashion to TCAs
|
|
Indications for SNRIs
|
First line for treatment of depression with comorbid neuropathic pain
Second line for depression failing SSRI therapy |
|
Major class side effects of SSRIs
|
Sexual dysfunction
Require 3-4 weeks for full efficacy May increase risk of suicidal ideation in adolescents Serotonin Syndrome |
|
Major class side effects of SNRIs
|
Hypertension
Nausea, dizziness, insomnia, sedation |
|
Class of imipramine
|
TCA
|
|
Class of amitriptyline
|
TCA
|
|
Class of Desipramine
|
TCA
|
|
Class of nortriptyline
|
TCA
|
|
MOA of TCAs
|
Blockade of norepinephrine and serotonin reuptake to potentiate postsynaptic receptor activity
|
|
Indications for TCAs
|
Second-line for treatment of depression
Useful in patients with comorbid neuropathic pain |
|
Major class side effects of TCAs
|
Cardiotoxicity - QTc prolongation
Sexual dysfunction Sedation Anticholinergic symptoms Lethal in overdose |
|
Class of Phenelzine
|
MAOI
|
|
Class of isocarboxazid
|
MAOI
|
|
Class of tranylcopromine
|
MAOI
|
|
Class of selegiline
|
MAOI
|
|
MOA of MAOI
|
Blockade of monoamine oxidase activity to inhibit deamination of serotonin, norepinephrine and dopamine
|
|
Indications for MAOIs
|
Third-line for depression
Useful for treatment of depression with neurologic symptoms, or refractory cases |
|
MOA of bupropion
|
Inhibition of dopamine and norepinephrine reuptake
|
|
Indications for duproprion
|
Depression with fatigue, difficulty concentrating, or comorbid ADHD
Smoking cessation |
|
Major class side effects of MAOIs
|
Dizziness, dry mouth, fatigue
Consumption of foods containing tyramine can cause hypertensive crisis |
|
Major side effects of buproprion
|
Insomnia, weight loss
NO sexual side effects |
|
MOA of Trazodone
|
Unknown; related to serotonin activity
|
|
Indications for trazodone
|
depression with significant insomnia
|
|
Major side effects of trazodone
|
Sedation, hypotension, nausea
Priapism Seizure risk at high doses |
|
Class of mirtazapine
|
Tetracyclic antidepressant
|
|
MOA of mirtazapine
|
blockade of alpha-2 adrenergic receptors and serotonin receptors to increase adrenergic neurotransmission
|
|
Indications of mitrazapine
|
Depression with insomnia
|
|
Major side effects of mirtazapine
|
Dry mouth, weight gain, sedation
|
|
Class of alprazolam
|
Benzodiazepine (short acting)
|
|
Class of clonazepam
|
Benzodiazepine (Long-acting)
|
|
Class of diazepam
|
Benzodiazepine (Long acting)
|
|
Class of lorzaepam
|
Benzodiazepine (Intermediate acting)
|
|
MOA of Benzodiazepines
|
Increase GABA inhibition of neuronal firing
|
|
Indications for benzodiazepines
|
Anxiolytic for panic attacks
Shrot-term treatment of insomnia Prevention of alcohol withdrawal |
|
Adverse effects of Benzodiazepines
|
sedation, confusion, Addition potential with withdrawal syndromes
|
|
MOA of buspirone
|
Unknown, but related to serotonin and dopamine receptors
|
|
Indication for buspirone
|
Anxiety disorders in which abuse or sedation is a concern
|
|
Side effects of buspirone
|
Headaches, dizziness, nausea
|
|
What is the antidote for benzodiazepine overdose?
|
Flumazenil
|
|
Class of Clozapine
|
Atypical Antipsychotic
|
|
Class of risperidone
|
Atypical Antipsychotic
|
|
Class of olanzapine
|
Atypical Antipsychotic
|
|
Class of sertindole
|
Atypical Antipsychotic
|
|
Class of quetiapine
|
Atypical Antipsychotic
|
|
Class of ziprasidone
|
Atypical Antipsychotic
|
|
Class of paliperidone
|
Atypical Antipsychotic
|
|
Class of ariipiprazole
|
Atypical Antipsychotic
|
|
MOA of Atypical Antipsychotics
|
Blockade of dopamine and serotonin receptors
|
|
Indications for Atypical Antipsychotics
|
First-line drugs for maintenance therapy for psychotic disorders
|
|
Major class side effects of Atypical Antipsychotics
|
Anticholinergic effects
Weight gain Seizures Arrhythmias Agranulocytosis |
|
Which atypical antipsychotic is the worst offender for metabolic issues?
|
Olanzapine
|
|
Which atypical antipsychotic is the worst offender for agranulocytosis?
|
Clozapine
|
|
Class of Haloperidol
|
High-potency Typical antipsychotics
|
|
Class of droperidol
|
High-potency Typical antipsychotics
|
|
Class of fluphenazine
|
High-potency Typical antipsychotics
|
|
Class of loxapine
|
High-potency Typical antipsychotics
|
|
Class of thiothixene
|
High-potency Typical antipsychotics
|
|
Class of perphenazine
|
High-potency Typical antipsychotics
|
|
Class of trifluoperazine
|
High-potency Typical antipsychotics
|
|
MOA of Typical antipsychotics
|
Blockade of D2 receptors
|
|
Indications for high-potentcy typical antipsychotics
|
Strong positive symptoms
Emergency control of agitation or psychosis Second-line for maintenance therapy |
|
Major class side effects of High-potency Typical antipsychotics
|
Extrapyramidal symptoms (Dystonia, parkinsonism, akinesia, akathisia)
Tardive dyskinesia Sexual dysfunction Neuroleptic malignant syndrome |
|
Class of thioridazine
|
Low-potency typical antipsychotic
|
|
Class of chlorpromazine
|
Low-potency typical antipsychotic
|
|
Indications for low-potency typical antipsychotics
|
Strong positive symptoms
Second line for maintenance therapy |
|
Major class side effects of low-potency typical antipsychotics
|
Fewer extrapyramidal side effects
Anticholinergic effects |